Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Rubin

Showing results (71-80 of 566) with videos related to

Pageof 57
Sort By:
World Journal of Gastroenterology|February 2, 2012
Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel diseaseTauseef Ali, Laura Yun, David T Rubin
Gastroenterology & Hepatology|May 26, 2021
A Practical Clinical Approach to the Management of High-Risk Ulcerative ColitisDavid T Rubin, Cindy Traboulsi, Victoria Rai
Gastrointestinal Endoscopy Clinics of North America|May 13, 2019
The Era of Anti-Tumor Necrosis Factor Is Over. What Do We Know, What Don't We Know, and What Do We Yearn to Know?Sujaata Dwadasi, Amanda Israel, David T Rubin
Intestinal Research|November 3, 2020
Pouchitis in inflammatory bowel disease: a review of diagnosis, prognosis, and treatmentShintaro Akiyama, Victoria Rai, David T Rubin
Gastroenterology|December 3, 2014
Patchy colitis and interstitial lung diseaseEmmanuel Coronel, Dejan Micic, David T Rubin
Expert Review of Gastroenterology & Hepatology|January 27, 2016
Vedolizumab in the treatment of Crohn's diseaseDino Tarabar, Ayal Hirsch, David T Rubin
Intestinal Research|March 13, 2024
The evolving understanding of histology as an endpoint in ulcerative colitisShintaro Akiyama, Yusuke Miyatani, David T Rubin
Inflammatory Bowel Diseases|July 22, 2015
U.S. Patients with Ulcerative Colitis Do Not Have a Decreased Risk of DiverticulosisJami Kinnucan, Justin Tomal, David T Rubin
Gastroenterology|April 8, 2021
ReplyGil Melmed, David T Rubin, Dermot McGovern
Gastroenterology & Hepatology|May 7, 2014
Ethical considerations for clinical trials in inflammatory bowel diseaseDavid T Rubin, Samuel Becker, Mark Siegler
Pageof 57

Showing results (71-80 of 566) with videos related to

Sort By:
Pageof 57
World Journal of Gastroenterology|February 2, 2012
Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel diseaseTauseef Ali, Laura Yun, David T Rubin
Gastroenterology & Hepatology|May 26, 2021
A Practical Clinical Approach to the Management of High-Risk Ulcerative ColitisDavid T Rubin, Cindy Traboulsi, Victoria Rai
Gastrointestinal Endoscopy Clinics of North America|May 13, 2019
The Era of Anti-Tumor Necrosis Factor Is Over. What Do We Know, What Don't We Know, and What Do We Yearn to Know?Sujaata Dwadasi, Amanda Israel, David T Rubin
Intestinal Research|November 3, 2020
Pouchitis in inflammatory bowel disease: a review of diagnosis, prognosis, and treatmentShintaro Akiyama, Victoria Rai, David T Rubin
Gastroenterology|December 3, 2014
Patchy colitis and interstitial lung diseaseEmmanuel Coronel, Dejan Micic, David T Rubin
Expert Review of Gastroenterology & Hepatology|January 27, 2016
Vedolizumab in the treatment of Crohn's diseaseDino Tarabar, Ayal Hirsch, David T Rubin
Intestinal Research|March 13, 2024
The evolving understanding of histology as an endpoint in ulcerative colitisShintaro Akiyama, Yusuke Miyatani, David T Rubin
Inflammatory Bowel Diseases|July 22, 2015
U.S. Patients with Ulcerative Colitis Do Not Have a Decreased Risk of DiverticulosisJami Kinnucan, Justin Tomal, David T Rubin
Gastroenterology|April 8, 2021
ReplyGil Melmed, David T Rubin, Dermot McGovern
Gastroenterology & Hepatology|May 7, 2014
Ethical considerations for clinical trials in inflammatory bowel diseaseDavid T Rubin, Samuel Becker, Mark Siegler
Pageof 57